Sana Biotechnology Inc. (SANA)
1.59
-0.12 (-7.02%)
At close: Mar 31, 2025, 10:36 AM
Sana Biotechnology Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -266.76M | -283.25M | -269.48M | -355.93M | -285.31M | -130.78M | -13.25M |
| Depreciation & Amortization | 17.39M | 24.56M | 15.63M | 11.07M | 5.92M | 1.83M | 1K |
| Stock-Based Compensation | 37.68M | 35.53M | 38.34M | 22.36M | 5.83M | 1.5M | 118K |
| Other Working Capital | -2.56M | 17.58M | 6.48M | 10.07M | 4.17M | 10.95M | -597K |
| Other Non-Cash Items | -10.28M | -49.03M | -82.08M | 61.64M | 129.42M | 38.97M | -228K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -7.55M | n/a |
| Change in Working Capital | -1.19M | 18.61M | 7.54M | 9.8M | 6.16M | 10.53M | -308K |
| Operating Cash Flow | -223.15M | -253.58M | -290.05M | -251.05M | -137.98M | -85.5M | -13.49M |
| Capital Expenditures | -33.43M | -20.03M | -20.88M | -29.86M | -23.87M | -26.18M | -460K |
| Acquisitions | n/a | -192.04K | -231.44K | n/a | 228.69K | -3.19M | n/a |
| Purchase of Investments | n/a | -157.74M | -78.69M | -491.39M | -387.43M | -141.52M | n/a |
| Sales Maturities Of Investments | n/a | 349.79M | 310.13M | 280.02M | 158.74M | 82.98M | n/a |
| Other Investing Acitivies | 17.45M | 192.04K | 231.44K | -4.57M | -228.69K | 59K | -320K |
| Investing Cash Flow | 17.45M | 172.01M | 210.56M | -245.8M | -252.56M | -87.86M | -780K |
| Debt Repayment | 7.74M | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 11.01M | n/a | n/a | n/a | 435.69M | 223.72M | n/a |
| Financial Cash Flow | 199.75M | 31.65M | 4.91M | 631.75M | 435.69M | 223.73M | 45.72M |
| Net Cash Flow | -5.95M | -49.92M | -74.58M | 134.9M | 45.14M | 50.36M | 31.45M |
| Free Cash Flow | -256.58M | -273.61M | -310.93M | -280.92M | -161.85M | -111.69M | -13.96M |